|
1.
|
Opioid Use Disorder (OUD) is an ongoing epidemic that effects millions of individuals worldwide. There is limited research on OUD in patients with cancer and standardized [...]
2024-04-08 |
Capstone |
|
|
2.
|
Cancer-related pain is ubiquitous. Targeted procedural interventions may be an important and under-utilized method for improving cancer-related pain and quality of life. [...]
2023-09-13 |
Abstract |
|
|
3.
|
Owing to the low heating efficiency of currently available magnetic nanoparticles, it is challenging to reach therapeutic temperatures above 44 0C in tumors that are gene [...]
2023-09-11 |
Abstract |
|
|
4.
|
Immune checkpoint inhibitors have shown success in treating a subset of patients with certain late-stage cancers. However, these treatments fail in many other patients, d [...]
2023-08-18 |
Abstract |
|
|
5.
|
Liquid biopsy provides a minimally-invasive alternative to solid tissue biopsy for assessing tumor-derived molecules such as circulating tumor DNA (ctDNA). Detection and [...]
2023 |
Dissertation |
|
|
6.
|
Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the GI tract. The second most common type of GIST is driven by oncogenic mutations in PDGFRA, of which [...]
2021 |
Abstract |
|
|
7.
|
As a part of the Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) precision medicine cancer trial, serial biopsies from cancer patients ar [...]
2021 |
Abstract |
|
|
8.
|
Abnormal splicing events can promote drug resistance in a variety of cancer types, however, the full extent of genome-wide splicing in therapy-resistant AML is not fully [...]
2020 |
Abstract |
|
|
9.
|
Millions of patients are diagnosed annually with a pulmonary nodule and related follow up can cause psychosocial harms such as lung cancer worry, depression, and anxiety. [...]
2020 |
Abstract |
|
|
10.
|
Recent research shows that microRNAs (miRNAs) may be potential biomarkers of cancer. MiRNAs are noncoding RNA molecules that regulate gene expression in the post-transcri [...]
2020 |
Abstract |
|
